Your browser doesn't support javascript.
loading
APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R.
Okamoto, Koji; Rausch, Jason W; Wakashin, Hidefumi; Fu, Yulong; Chung, Joon-Yong; Dummer, Patrick D; Shin, Myung K; Chandra, Preeti; Suzuki, Kosuke; Shrivastav, Shashi; Rosenberg, Avi Z; Hewitt, Stephen M; Ray, Patricio E; Noiri, Eisei; Le Grice, Stuart F J; Hoek, Maarten; Han, Zhe; Winkler, Cheryl A; Kopp, Jeffrey B.
Afiliación
  • Okamoto K; Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
  • Rausch JW; Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
  • Wakashin H; Department of Nephrology, Endocrinology, Hemodialysis & Apheresis, University Hospital, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 133-8655, Japan.
  • Fu Y; Reverse Transcriptase Biochemistry Section, Basic Research Program, Frederick National Laboratory for Cancer Research, 1050 Boyle Street, Frederick, MD, 21702, USA.
  • Chung JY; Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
  • Dummer PD; Children's National Health System, 111 Michigan Ave NW, Washington, DC, 20010, USA.
  • Shin MK; Experimental Pathology Lab, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
  • Chandra P; Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
  • Suzuki K; Merck Research Laboratories, Merck and Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ, 07033, USA.
  • Shrivastav S; Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.
  • Rosenberg AZ; Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
  • Hewitt SM; Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
  • Ray PE; Department of Pathology, Johns Hopkins Medical Institutions, 720 Rutland Avenue, Baltimore, MD, 21287, USA.
  • Noiri E; Experimental Pathology Lab, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
  • Le Grice SFJ; Children's National Health System, 111 Michigan Ave NW, Washington, DC, 20010, USA.
  • Hoek M; Department of Nephrology, Endocrinology, Hemodialysis & Apheresis, University Hospital, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 133-8655, Japan.
  • Han Z; Reverse Transcriptase Biochemistry Section, Basic Research Program, Frederick National Laboratory for Cancer Research, 1050 Boyle Street, Frederick, MD, 21702, USA.
  • Winkler CA; Merck Research Laboratories, Merck and Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ, 07033, USA.
  • Kopp JB; Children's National Health System, 111 Michigan Ave NW, Washington, DC, 20010, USA.
Commun Biol ; 1: 188, 2018.
Article en En | MEDLINE | ID: mdl-30417125
ABSTRACT
APOL1 risk alleles associate with chronic kidney disease in African Americans, but the mechanisms remain to be fully understood. We show that APOL1 risk alleles activate protein kinase R (PKR) in cultured cells and transgenic mice. This effect is preserved when a premature stop codon is introduced to APOL1 risk alleles, suggesting that APOL1 RNA but not protein is required for the effect. Podocyte expression of APOL1 risk allele RNA, but not protein, in transgenic mice induces glomerular injury and proteinuria. Structural analysis of the APOL1 RNA shows that the risk variants possess secondary structure serving as a scaffold for tandem PKR binding and activation. These findings provide a mechanism by which APOL1 variants damage podocytes and suggest novel therapeutic strategies.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Commun Biol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Commun Biol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos